|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7600 EUR | -2.06% |
|
-0.13% | -28.17% |
| 07-01 | Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France | CI |
| 06-30 | Amoéba gains from marketing authorization in France |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.822 | 0.9 | 0.936 |
| Spread/Res. | -7.54% | -15.56% | -18.80% |
| Spread/Supp. | +0.93% | +0.93% | +0.93% |
| Support | 0.753 | 0.753 | 0.753 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALMIB Stock
- Charts Amoéba
Select your edition
All financial news and data tailored to specific country editions
